XOMA Corp. (XOMA) NASDAQ
$15.95 (0.09) (-0.56%)
Market Cap: $183.23M
As of 12/08/23 04:00 PM EST. Market closed.
XOMA Corp. (XOMA)
NASDAQ
$15.95
(0.09) (-0.56%)
Market Cap: $183.23M
As of 12/08/23 04:00 PM EST. Market closed.
Add to Portfolio
xoma has an extensive portfolio of products, programs, and technologies that are the subject of licenses the company has in place with other biotech and pharmaceutical companies. many of these licenses are the result of the company's pioneering efforts in the discovery and development of antibody therapeutics. there are more than 20 such programs that are fully funded by partners and could ... read more
xoma has an extensive portfolio of products, programs, and technologies that are the subject of licenses the company has in place with other biotech and pharmaceutical companies. many of these licenses are the result of the company's pioneering efforts in the discovery and development of antibody therapeutics. there are more than 20 such programs that are fully funded by partners and could produce milestone payments and royalty payments in the future. in order to maximize its value in a licensing transaction, xoma continues to invest in x358, an allosteric monoclonal antibody that reduces insulin receptor activity, as the antibody could have a major impact on the treatment of hyperinsulinism. for more information, visit www.xoma.com. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
CEO Compensation (Base)
$484,100
CEO Compensation (Total)
$1.32M
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
123
CEO Compensation (Base)
$484,100
CEO Compensation (Total)
$1.32M
URL
Address
2910 7th St, California, Berkeley, 94710-2700.
PRICE CHART FOR XOMA CORP
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$15.87
Previous Close
$16.04
Days Range
$15.45 - $16.40
52 week range
$13.48 - $23.51
Volume
20,632
Avg. Volume (30 days)
24,129
Market Cap
$183.23M
Dividend Yield
-
P/E
(5.70)
Shares Outstanding
11,487,808
Open
$15.87
Previous Close
$16.04
Days Range
$15.45 - $16.40
52 week range
$13.48 - $23.51
Volume
20,632
Avg. Volume (30 days)
24,129
Market Cap
$183.23M
Dividend Yield
-
P/E
(5.70)
Shares Outstanding
11,487,808
FINANCIAL STATEMENTS FOR XOMA CORP
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR XOMA CORP
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Sitko Bradley | Chief Investment Officer | Oct 02, 2023 | Buy | $14.25 | 1,500 | 21,375 | 5,350 | Oct 04, 2023, 04:30 PM |
| Sitko Bradley | Chief Investment Officer | Oct 03, 2023 | Buy | $13.89 | 250 | 3,473 | 5,600 | Oct 04, 2023, 04:30 PM |
| Hughes Owen | Exec Chairman and Interim CEO | Oct 02, 2023 | Buy | $13.83 | 1,000 | 13,830 | 3,500 | Oct 04, 2023, 04:30 PM |
| Hughes Owen | Exec Chairman and Interim CEO | Sep 26, 2023 | Buy | $14.43 | 2,499 | 36,061 | 2,500 | Sep 27, 2023, 04:30 PM |
| Hughes Owen | Exec Chairman and Interim CEO | Sep 25, 2023 | Buy | $14.65 | 1 | 15 | 1 | Sep 27, 2023, 04:30 PM |
| Sitko Bradley | Chief Investment Officer | May 31, 2023 | Buy | $17.13 | 1,500 | 25,700 | 3,500 | Jun 02, 2023, 04:30 PM |
| Sitko Bradley | Chief Investment Officer | May 23, 2023 | Buy | $19.00 | 850 | 16,150 | 3,850 | May 25, 2023, 04:30 PM |
| Hughes Owen | Interim CEO | May 23, 2023 | Buy | $23.46 | 968 | 22,706 | 968 | May 25, 2023, 04:30 PM |
| Hughes Owen | Interim CEO | May 24, 2023 | Buy | $23.79 | 1,032 | 24,551 | 2,000 | May 25, 2023, 04:30 PM |
| Sitko Bradley | Chief Investment Officer | May 19, 2023 | Buy | $19.50 | 1,000 | 19,500 | 3,000 | May 22, 2023, 04:30 PM |
| Sitko Bradley | Chief Investment Officer | May 16, 2023 | Buy | $23.20 | 500 | 11,602 | 2,000 | May 17, 2023, 05:20 PM |
| Sitko Bradley | Chief Investment Officer | May 15, 2023 | Buy | $23.40 | 1,500 | 35,100 | 1,500 | May 16, 2023, 04:13 PM |
| Sitko Bradley | Chief Investment Officer | May 12, 2023 | Buy | $18.99 | 2,000 | 37,985 | 2,000 | May 16, 2023, 04:13 PM |
| BVF PARTNERS L P/IL | Director | Jan 06, 2023 | Buy | $21.98 | 3,249 | 71,419 | 1,789,844 | Jan 09, 2023, 05:44 PM |
| BVF PARTNERS L P/IL | Director | Jan 05, 2023 | Buy | $18.39 | 19,000 | 349,319 | 1,788,168 | Jan 09, 2023, 05:44 PM |
| BVF PARTNERS L P/IL | Director | Sep 27, 2022 | Buy | $16.89 | 1,682 | 28,409 | 1,784,838 | Sep 27, 2022, 07:22 PM |
| BVF PARTNERS L P/IL | Director | Sep 26, 2022 | Buy | $16.83 | 6,360 | 107,050 | 1,783,834 | Sep 27, 2022, 07:22 PM |
| BVF PARTNERS L P/IL | Director | Sep 23, 2022 | Buy | $16.50 | 16,600 | 273,850 | 1,780,495 | Sep 27, 2022, 07:22 PM |
| BVF PARTNERS L P/IL | Director | Sep 16, 2022 | Buy | $17.89 | 24,293 | 434,536 | 1,773,780 | Sep 16, 2022, 06:30 PM |
| BVF PARTNERS L P/IL | Director | Sep 15, 2022 | Buy | $17.96 | 5,575 | 100,138 | 1,576,913 | Sep 16, 2022, 06:30 PM |
| BVF PARTNERS L P/IL | Director | Sep 14, 2022 | Buy | $17.25 | 26,441 | 456,044 | 1,571,338 | Sep 16, 2022, 06:30 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Jul 15, 2022 | Option Exercise | $4.03 | 2,000 | 8,060 | 8,555 | Jul 18, 2022, 04:30 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Jul 15, 2022 | Sale | $31.66 | 2,000 | 63,321 | 6,555 | Jul 18, 2022, 04:30 PM |
| Neal James R | CEO | Jul 15, 2022 | Option Exercise | $4.03 | 25,000 | 100,750 | 36,822 | Jul 18, 2022, 04:30 PM |
| Neal James R | CEO | Jul 15, 2022 | Sale | $29.84 | 25,000 | 746,104 | 15,939 | Jul 18, 2022, 04:30 PM |
| Neal James R | CEO | Mar 22, 2022 | Option Exercise | $4.03 | 2,339 | 9,426 | 14,161 | Mar 23, 2022, 06:52 PM |
| Neal James R | CEO | Mar 21, 2022 | Option Exercise | $4.03 | 50,000 | 201,500 | 61,822 | Mar 23, 2022, 06:52 PM |
| Neal James R | CEO | Mar 23, 2022 | Option Exercise | $4.03 | 1,111 | 4,477 | 12,933 | Mar 23, 2022, 06:52 PM |
| Neal James R | CEO | Mar 21, 2022 | Sale | $29.00 | 50,000 | 1,450,250 | 11,822 | Mar 23, 2022, 06:52 PM |
| Neal James R | CEO | Mar 23, 2022 | Sale | $30.02 | 1,111 | 33,348 | 11,822 | Mar 23, 2022, 06:52 PM |
| Neal James R | CEO | Mar 22, 2022 | Sale | $30.02 | 2,339 | 70,209 | 11,822 | Mar 23, 2022, 06:52 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Mar 21, 2022 | Option Exercise | $4.03 | 12,000 | 48,360 | 18,555 | Mar 23, 2022, 06:52 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Mar 23, 2022 | Option Exercise | $4.03 | 161 | 649 | 6,716 | Mar 23, 2022, 06:52 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Mar 22, 2022 | Option Exercise | $4.03 | 2,339 | 9,426 | 8,894 | Mar 23, 2022, 06:52 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Mar 21, 2022 | Sale | $29.00 | 12,000 | 348,060 | 6,555 | Mar 23, 2022, 06:52 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Mar 23, 2022 | Sale | $30.00 | 161 | 4,830 | 6,555 | Mar 23, 2022, 06:52 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Mar 22, 2022 | Sale | $30.02 | 2,339 | 70,209 | 6,555 | Mar 23, 2022, 06:52 PM |
| Neal James R | CEO | Apr 09, 2021 | Option Exercise | $25.00 | 8,000 | 200,000 | 8,000 | Apr 13, 2021, 04:30 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Apr 09, 2021 | Option Exercise | $25.00 | 1,000 | 25,000 | 1,000 | Apr 13, 2021, 04:30 PM |
| VAN NESS W DENMAN | Director | Mar 15, 2021 | Option Exercise | $10.41 | 5,699 | 59,332 | 15,643 | Mar 16, 2021, 04:30 PM |
| Neal James R | CEO | Dec 15, 2020 | Option Exercise | $25.00 | 8,000 | 200,000 | 8,000 | Dec 17, 2020, 04:30 PM |
| Neal James R | CEO | Dec 15, 2020 | Option Exercise | $5.50 | 26,000 | 143,000 | 46,849 | Dec 17, 2020, 04:30 PM |
| Neal James R | CEO | Dec 15, 2020 | Sale | $41.35 | 26,000 | 1,074,998 | 26,555 | Dec 17, 2020, 04:30 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Dec 15, 2020 | Option Exercise | $25.00 | 2,000 | 50,000 | 2,000 | Dec 17, 2020, 04:30 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Dec 15, 2020 | Option Exercise | $4.03 | 15,000 | 60,450 | 21,555 | Dec 17, 2020, 04:30 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Dec 15, 2020 | Sale | $41.41 | 15,000 | 621,086 | 12,162 | Dec 17, 2020, 04:30 PM |
| Hernday Natasha | Director | Dec 15, 2020 | Option Exercise | $25.00 | 4,000 | 100,000 | 4,000 | Dec 17, 2020, 04:30 PM |
| PERRY MATTHEW D | Director | Dec 11, 2020 | Buy | $25.00 | 200,000 | 5,000,000 | 200,000 | Dec 15, 2020, 07:12 PM |
| BVF PARTNERS L P/IL | Director | Dec 11, 2020 | Buy | $25.00 | 200,000 | 5,000,000 | 200,000 | Dec 15, 2020, 07:09 PM |
| Neal James R | CEO | Nov 23, 2020 | Option Exercise | $5.50 | 13,126 | 72,193 | 33,975 | Nov 24, 2020, 04:30 PM |
| Neal James R | CEO | Nov 20, 2020 | Option Exercise | $5.50 | 6,874 | 37,807 | 27,723 | Nov 24, 2020, 04:30 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Nov 23, 2020 | Option Exercise | $4.03 | 5,125 | 20,654 | 11,680 | Nov 24, 2020, 04:30 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Nov 20, 2020 | Option Exercise | $4.03 | 6,875 | 27,706 | 13,430 | Nov 24, 2020, 04:30 PM |
| Neal James R | CEO | Nov 20, 2020 | Sale | $32.52 | 6,874 | 223,523 | 21,275 | Nov 24, 2020, 04:30 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Nov 23, 2020 | Sale | $32.93 | 5,125 | 168,752 | 6,555 | Nov 24, 2020, 04:30 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Nov 20, 2020 | Sale | $32.52 | 6,875 | 223,555 | 6,981 | Nov 24, 2020, 04:30 PM |
| Neal James R | CEO | Nov 23, 2020 | Sale | $32.96 | 13,126 | 432,662 | 20,849 | Nov 24, 2020, 04:30 PM |
| Neal James R | CEO | Nov 05, 2020 | Option Exercise | $5.50 | 10,000 | 55,000 | 30,849 | Nov 06, 2020, 05:20 PM |
| Neal James R | CEO | Nov 05, 2020 | Sale | $26.02 | 10,000 | 260,205 | 21,576 | Nov 06, 2020, 05:20 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Nov 05, 2020 | Option Exercise | $4.03 | 8,000 | 32,240 | 14,555 | Nov 06, 2020, 05:20 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Nov 05, 2020 | Sale | $26.11 | 8,000 | 208,908 | 7,281 | Nov 06, 2020, 05:20 PM |
| BVF PARTNERS L P/IL | Director | Sep 23, 2020 | Buy | $18.20 | 17,089 | 311,016 | 2,040,124 | Sep 23, 2020, 07:26 PM |
| BVF PARTNERS L P/IL | Director | Sep 22, 2020 | Buy | $18.45 | 11,951 | 220,445 | 2,030,236 | Sep 23, 2020, 07:26 PM |
| BVF PARTNERS L P/IL | Director | Sep 21, 2020 | Buy | $18.39 | 22,328 | 410,502 | 2,023,276 | Sep 23, 2020, 07:26 PM |
| BVF PARTNERS L P/IL | Director | Sep 04, 2020 | Buy | $18.77 | 7,737 | 145,228 | 2,011,017 | Sep 10, 2020, 08:10 AM |
| BVF PARTNERS L P/IL | Director | Aug 28, 2020 | Buy | $19.17 | 2,044 | 39,187 | 1,988,067 | Sep 01, 2020, 08:37 PM |
| BVF PARTNERS L P/IL | Director | Sep 01, 2020 | Buy | $18.87 | 17,572 | 331,515 | 2,007,110 | Sep 01, 2020, 08:37 PM |
| BVF PARTNERS L P/IL | Director | Aug 31, 2020 | Buy | $18.48 | 16,005 | 295,782 | 1,997,210 | Sep 01, 2020, 08:37 PM |
| BVF PARTNERS L P/IL | Director | Aug 25, 2020 | Buy | $19.75 | 5,687 | 112,290 | 1,986,945 | Aug 25, 2020, 08:10 PM |
| BVF PARTNERS L P/IL | Director | Aug 24, 2020 | Buy | $19.31 | 11,683 | 225,591 | 1,983,502 | Aug 25, 2020, 08:10 PM |
| BVF PARTNERS L P/IL | Director | Aug 21, 2020 | Buy | $19.32 | 10,805 | 208,770 | 1,976,998 | Aug 25, 2020, 08:10 PM |
| BVF PARTNERS L P/IL | 10% Owner | Aug 18, 2020 | Buy | $19.27 | 895 | 17,246 | 1,962,532 | Aug 20, 2020, 06:56 PM |
| BVF PARTNERS L P/IL | 10% Owner | Aug 20, 2020 | Buy | $19.12 | 1,772 | 33,881 | 1,967,800 | Aug 20, 2020, 06:56 PM |
| BVF PARTNERS L P/IL | 10% Owner | Aug 19, 2020 | Buy | $19.70 | 3,496 | 68,877 | 1,966,028 | Aug 20, 2020, 06:56 PM |
| BVF PARTNERS L P/IL | 10% Owner | Aug 14, 2020 | Buy | $18.69 | 21,922 | 409,810 | 1,961,637 | Aug 14, 2020, 06:38 PM |
| BVF PARTNERS L P/IL | 10% Owner | Aug 13, 2020 | Buy | $17.80 | 1,050 | 18,693 | 1,939,715 | Aug 14, 2020, 06:38 PM |
| BVF PARTNERS L P/IL | 10% Owner | Aug 12, 2020 | Buy | $17.34 | 4,050 | 70,233 | 1,938,665 | Aug 14, 2020, 06:38 PM |
| BVF PARTNERS L P/IL | 10% Owner | Apr 15, 2020 | Option Exercise | $13.00 | 1,252,772 | 16,286,036 | 1,934,615 | Apr 17, 2020, 05:13 PM |
| BVF PARTNERS L P/IL | 10% Owner | Mar 25, 2020 | Buy | $17.20 | 8,264 | 142,129 | 1,278,656 | Mar 27, 2020, 08:29 PM |
| Neal James R | CEO | Mar 23, 2020 | Buy | $14.50 | 1,000 | 14,500 | 20,849 | Mar 24, 2020, 04:38 PM |
| Neal James R | CEO | Mar 20, 2020 | Buy | $16.41 | 1,000 | 16,410 | 19,849 | Mar 23, 2020, 04:30 PM |
| BVF PARTNERS L P/IL | 10% Owner | Mar 18, 2020 | Buy | $14.52 | 4,439 | 64,475 | 1,270,392 | Mar 20, 2020, 04:52 PM |
| BVF PARTNERS L P/IL | 10% Owner | Mar 17, 2020 | Buy | $15.73 | 8,113 | 127,648 | 1,265,953 | Mar 17, 2020, 09:30 PM |
| BVF PARTNERS L P/IL | 10% Owner | Mar 16, 2020 | Buy | $15.73 | 10,164 | 159,916 | 1,257,840 | Mar 17, 2020, 09:30 PM |
| BVF PARTNERS L P/IL | 10% Owner | Mar 13, 2020 | Buy | $18.34 | 100,000 | 1,834,090 | 1,247,676 | Mar 17, 2020, 09:30 PM |
| Neal James R | CEO | Dec 23, 2019 | Option Exercise | $22.00 | 1,180 | 25,960 | 18,849 | Jan 16, 2020, 05:33 PM |
| BVF PARTNERS L P/IL | 10% Owner | Dec 19, 2019 | Buy | $22.00 | 373,195 | 8,210,290 | 1,147,676 | Dec 20, 2019, 07:18 PM |
| BVF PARTNERS L P/IL | 10% Owner | Dec 18, 2019 | Option Exercise | $22.00 | 472,268 | 10,389,896 | 940,442 | Dec 20, 2019, 07:18 PM |
| Neal James R | CEO | Nov 06, 2019 | Option Exercise | $5.50 | 4,348 | 23,914 | 22,017 | Nov 08, 2019, 04:30 PM |
| Neal James R | CEO | Nov 06, 2019 | Sale | $22.00 | 4,348 | 95,656 | 17,669 | Nov 08, 2019, 04:30 PM |
| Neal James R | Chief Executive Officer | Sep 18, 2019 | Option Exercise | $5.50 | 3,830 | 21,065 | 21,499 | Sep 20, 2019, 07:40 PM |
| Neal James R | Chief Executive Officer | Sep 20, 2019 | Option Exercise | $5.50 | 5,452 | 29,986 | 23,121 | Sep 20, 2019, 07:40 PM |
| Neal James R | Chief Executive Officer | Sep 19, 2019 | Option Exercise | $5.50 | 6,370 | 35,035 | 24,039 | Sep 20, 2019, 07:40 PM |
| Neal James R | Chief Executive Officer | Sep 20, 2019 | Sale | $20.23 | 5,452 | 110,271 | 17,669 | Sep 20, 2019, 07:40 PM |
| Neal James R | Chief Executive Officer | Sep 19, 2019 | Sale | $21.12 | 6,370 | 134,544 | 20,311 | Sep 20, 2019, 07:40 PM |
| Neal James R | Chief Executive Officer | Sep 18, 2019 | Sale | $21.96 | 3,830 | 84,113 | 17,669 | Sep 20, 2019, 07:40 PM |
| BURNS THOMAS M. | Sr. VP, Finance and CFO | Sep 18, 2019 | Option Exercise | $4.03 | 3,829 | 15,431 | 10,384 | Sep 20, 2019, 07:39 PM |
| BURNS THOMAS M. | Sr. VP, Finance and CFO | Sep 19, 2019 | Option Exercise | $4.03 | 4,171 | 16,809 | 10,726 | Sep 20, 2019, 07:39 PM |
| BURNS THOMAS M. | Sr. VP, Finance and CFO | Sep 19, 2019 | Sale | $21.41 | 4,171 | 89,296 | 7,055 | Sep 20, 2019, 07:39 PM |
| BURNS THOMAS M. | Sr. VP, Finance and CFO | Sep 18, 2019 | Sale | $21.96 | 3,829 | 84,091 | 6,555 | Sep 20, 2019, 07:39 PM |
| BVF PARTNERS L P/IL | 10% Owner | May 14, 2019 | Buy | $14.74 | 13,816 | 203,664 | 746,454 | May 14, 2019, 09:01 PM |
| BVF PARTNERS L P/IL | 10% Owner | May 13, 2019 | Buy | $14.36 | 3,797 | 54,526 | 732,638 | May 14, 2019, 09:01 PM |
| BVF PARTNERS L P/IL | 10% Owner | May 10, 2019 | Buy | $14.57 | 10,300 | 150,037 | 728,841 | May 14, 2019, 09:01 PM |
| VAN NESS W DENMAN | Director | May 10, 2019 | Sale | $14.71 | 130 | 1,912 | 0 | May 14, 2019, 06:38 PM |
| Neal James R | CEO | Dec 20, 2018 | Option Exercise | $13.00 | 678 | 8,814 | 21,011 | Dec 21, 2018, 06:24 PM |
| VAN NESS W DENMAN | Director | Dec 20, 2018 | Option Exercise | $13.00 | 800 | 10,400 | 9,944 | Dec 21, 2018, 06:22 PM |
| BVF PARTNERS L P/IL | 10% Owner | Dec 17, 2018 | Buy | $14.19 | 25,000 | 354,792 | 718,541 | Dec 19, 2018, 09:26 PM |
| BVF PARTNERS L P/IL | 10% Owner | Dec 13, 2018 | Buy | $14.41 | 24,253 | 349,525 | 693,541 | Dec 13, 2018, 06:54 PM |
| BVF PARTNERS L P/IL | 10% Owner | Dec 12, 2018 | Buy | $14.75 | 2,810 | 41,448 | 669,288 | Dec 13, 2018, 06:54 PM |
| BVF PARTNERS L P/IL | 10% Owner | Dec 11, 2018 | Buy | $14.50 | 9,400 | 136,270 | 666,478 | Dec 13, 2018, 06:54 PM |
| BVF PARTNERS L P/IL | 10% Owner | Dec 06, 2018 | Buy | $14.80 | 10,927 | 161,698 | 606,982 | Dec 10, 2018, 07:03 PM |
| BVF PARTNERS L P/IL | 10% Owner | Dec 10, 2018 | Buy | $14.54 | 18,081 | 262,972 | 657,078 | Dec 10, 2018, 07:03 PM |
| BVF PARTNERS L P/IL | 10% Owner | Dec 07, 2018 | Buy | $14.77 | 32,015 | 472,778 | 638,997 | Dec 10, 2018, 07:03 PM |
| BVF PARTNERS L P/IL | 10% Owner | Dec 04, 2018 | Buy | $14.99 | 4,171 | 62,515 | 596,055 | Dec 04, 2018, 07:01 PM |
| BVF PARTNERS L P/IL | 10% Owner | Dec 03, 2018 | Buy | $14.90 | 806 | 12,009 | 591,884 | Dec 04, 2018, 07:01 PM |
| BVF PARTNERS L P/IL | 10% Owner | Nov 30, 2018 | Buy | $14.85 | 4,823 | 71,615 | 591,078 | Dec 04, 2018, 07:01 PM |
| BVF PARTNERS L P/IL | 10% Owner | Nov 29, 2018 | Buy | $14.93 | 10,016 | 149,543 | 586,255 | Nov 29, 2018, 05:55 PM |
| BVF PARTNERS L P/IL | 10% Owner | Nov 28, 2018 | Buy | $15.11 | 8,288 | 125,262 | 576,239 | Nov 29, 2018, 05:55 PM |
| BVF PARTNERS L P/IL | 10% Owner | Nov 27, 2018 | Buy | $15.24 | 11,396 | 173,680 | 567,951 | Nov 29, 2018, 05:55 PM |
| BVF PARTNERS L P/IL | 10% Owner | Nov 21, 2018 | Buy | $15.00 | 25,000 | 374,892 | 556,555 | Nov 21, 2018, 05:42 PM |
| BVF PARTNERS L P/IL | 10% Owner | Nov 20, 2018 | Buy | $13.68 | 37,482 | 512,701 | 531,555 | Nov 21, 2018, 05:42 PM |
| BVF PARTNERS L P/IL | 10% Owner | Nov 19, 2018 | Buy | $13.93 | 9,771 | 136,064 | 494,073 | Nov 21, 2018, 05:42 PM |
| BVF PARTNERS L P/IL | 10% Owner | Nov 16, 2018 | Buy | $13.82 | 10,849 | 149,986 | 484,302 | Nov 19, 2018, 10:21 AM |
| BVF PARTNERS L P/IL | 10% Owner | Nov 15, 2018 | Buy | $13.31 | 21,141 | 281,361 | 473,453 | Nov 19, 2018, 10:21 AM |
| VAN NESS W DENMAN | Director | Nov 15, 2018 | Option Exercise | $6.85 | 7,693 | 52,699 | 14,672 | Nov 16, 2018, 04:31 PM |
| VAN NESS W DENMAN | Director | Nov 15, 2018 | Sale | $12.67 | 5,528 | 70,040 | 9,144 | Nov 16, 2018, 04:31 PM |
| Neal James R | CEO | Nov 13, 2018 | Buy | $13.26 | 4,000 | 53,056 | 20,333 | Nov 15, 2018, 04:09 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Apr 27, 2018 | Option Exercise | $5.50 | 2,655 | 14,603 | 9,210 | Apr 27, 2018, 05:44 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Apr 26, 2018 | Option Exercise | $5.50 | 8,345 | 45,898 | 14,900 | Apr 27, 2018, 05:44 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Apr 27, 2018 | Sale | $24.77 | 2,655 | 65,757 | 6,555 | Apr 27, 2018, 05:44 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Apr 26, 2018 | Sale | $24.69 | 8,345 | 206,050 | 6,555 | Apr 27, 2018, 05:44 PM |
| Neal James R | CEO | Apr 27, 2018 | Option Exercise | $5.50 | 15,655 | 86,103 | 31,988 | Apr 27, 2018, 05:44 PM |
| Neal James R | CEO | Apr 26, 2018 | Option Exercise | $5.50 | 8,345 | 45,898 | 24,678 | Apr 27, 2018, 05:44 PM |
| Neal James R | CEO | Apr 27, 2018 | Sale | $24.42 | 15,655 | 382,236 | 16,333 | Apr 27, 2018, 05:44 PM |
| Neal James R | CEO | Apr 26, 2018 | Sale | $24.69 | 8,345 | 206,050 | 16,333 | Apr 27, 2018, 05:44 PM |
| Neal James R | CEO | Nov 14, 2017 | Option Exercise | $4.03 | 8,583 | 34,589 | 24,916 | Nov 15, 2017, 08:03 PM |
| Neal James R | CEO | Nov 13, 2017 | Option Exercise | $4.03 | 11,568 | 46,619 | 27,901 | Nov 15, 2017, 08:03 PM |
| Neal James R | CEO | Nov 15, 2017 | Option Exercise | $4.03 | 26,145 | 105,364 | 42,478 | Nov 15, 2017, 08:03 PM |
| Neal James R | CEO | Nov 13, 2017 | Sale | $30.83 | 11,568 | 356,674 | 16,817 | Nov 15, 2017, 08:03 PM |
| Neal James R | CEO | Nov 15, 2017 | Sale | $27.03 | 26,145 | 706,766 | 18,533 | Nov 15, 2017, 08:03 PM |
| Neal James R | CEO | Nov 14, 2017 | Sale | $28.40 | 8,583 | 243,747 | 21,397 | Nov 15, 2017, 08:03 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Nov 14, 2017 | Option Exercise | $4.03 | 6,847 | 27,593 | 13,402 | Nov 15, 2017, 08:03 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Nov 13, 2017 | Option Exercise | $4.03 | 6,983 | 28,141 | 13,538 | Nov 15, 2017, 08:03 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Nov 15, 2017 | Option Exercise | $4.03 | 8,392 | 33,820 | 14,947 | Nov 15, 2017, 08:03 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Nov 13, 2017 | Sale | $30.99 | 6,983 | 216,419 | 7,041 | Nov 15, 2017, 08:03 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Nov 15, 2017 | Sale | $27.05 | 8,392 | 226,978 | 6,755 | Nov 15, 2017, 08:03 PM |
| BURNS THOMAS M. | SVP, Finance & CFO | Nov 14, 2017 | Sale | $28.34 | 6,847 | 194,053 | 10,585 | Nov 15, 2017, 08:03 PM |
| Varian John | Director | May 16, 2017 | Sale | $6.24 | 39,540 | 246,919 | 2,344 | May 18, 2017, 03:02 PM |
| Neal James R | VP Business Development | Mar 21, 2017 | Sale | $5.40 | 5,105 | 27,569 | 15,366 | Mar 23, 2017, 10:45 AM |
| BURNS THOMAS M. | VP, Finance & Chief Financial | Mar 21, 2017 | Sale | $5.40 | 2,598 | 14,030 | 6,555 | Mar 23, 2017, 10:31 AM |
| Neal James R | VP Business Development | Feb 01, 2017 | Sale | $4.52 | 195 | 881 | 20,566 | Feb 01, 2017, 04:47 PM |
| Neal James R | VP Business Development | Jan 09, 2017 | Sale | $5.15 | 125 | 644 | 20,666 | Jan 10, 2017, 12:21 PM |
| Varian John | Director | Dec 21, 2016 | Sale | $5.75 | 13,549 | 77,907 | 41,884 | Dec 23, 2016, 06:38 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Dec 21, 2016 | Sale | $5.75 | 3,230 | 18,573 | 8,217 | Dec 23, 2016, 06:36 PM |
| Neal James R | VP Business Development | Nov 01, 2016 | Sale | $5.25 | 150 | 788 | 20,541 | Nov 03, 2016, 07:38 PM |
| Neal James R | VP Business Development | Oct 07, 2016 | Sale | $0.45 | 2,500 | 1,120 | 413,839 | Oct 11, 2016, 05:26 PM |
| BURNS THOMAS M. | VP, Finance & Chief Financial | Mar 22, 2016 | Sale | $0.78 | 19,249 | 15,105 | 183,071 | Mar 22, 2016, 09:05 PM |
| Neal James R | VP Business Development | Mar 22, 2016 | Sale | $0.78 | 19,813 | 15,547 | 411,339 | Mar 22, 2016, 09:03 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Mar 22, 2016 | Sale | $0.78 | 24,194 | 18,985 | 326,601 | Mar 22, 2016, 09:01 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Mar 22, 2016 | Sale | $0.78 | 14,785 | 11,602 | 228,942 | Mar 22, 2016, 08:58 PM |
| Varian John | CEO | Mar 22, 2016 | Sale | $0.78 | 81,022 | 63,578 | 1,108,673 | Mar 22, 2016, 08:55 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Feb 01, 2016 | Sale | $1.01 | 8,000 | 8,080 | 94,227 | Feb 03, 2016, 04:46 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Dec 28, 2015 | Sale | $1.37 | 8,000 | 10,937 | 102,227 | Dec 30, 2015, 05:05 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Nov 23, 2015 | Sale | $1.35 | 8,000 | 10,800 | 110,227 | Nov 25, 2015, 06:14 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Oct 26, 2015 | Sale | $1.04 | 8,000 | 8,358 | 118,227 | Oct 28, 2015, 05:44 PM |
| Varian John | CEO | Aug 14, 2015 | Option Exercise | $0.83 | 35,799 | 29,838 | 516,615 | Aug 18, 2015, 09:24 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Aug 14, 2015 | Option Exercise | $0.83 | 6,157 | 5,132 | 109,963 | Aug 18, 2015, 09:20 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Aug 14, 2015 | Option Exercise | $0.83 | 10,801 | 9,003 | 138,292 | Aug 18, 2015, 08:24 PM |
| Neal James R | VP Business Development | Aug 14, 2015 | Option Exercise | $0.83 | 9,067 | 7,557 | 175,402 | Aug 18, 2015, 07:49 PM |
| BAKER BROS. ADVISORS LP | Former 10% owner | Jul 22, 2015 | Sale | $1.09 | 11,000,000 | 12,017,500 | 3,153,539 | Jul 23, 2015, 05:35 PM |
| Varian John | CEO | Jul 15, 2015 | Option Exercise | $1.24 | 10,000 | 12,400 | 562,414 | Jul 17, 2015, 06:03 PM |
| Varian John | CEO | Jul 15, 2015 | Sale | $4.49 | 10,000 | 44,869 | 552,414 | Jul 17, 2015, 06:03 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Jul 15, 2015 | Option Exercise | $3.04 | 5,000 | 15,200 | 127,345 | Jul 17, 2015, 06:02 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Jul 15, 2015 | Sale | $4.60 | 5,000 | 22,992 | 122,345 | Jul 17, 2015, 06:02 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Jul 10, 2015 | Option Exercise | $3.04 | 29,000 | 88,160 | 151,345 | Jul 10, 2015, 06:57 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Jul 09, 2015 | Option Exercise | $3.04 | 4,400 | 13,376 | 126,745 | Jul 10, 2015, 06:57 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Jul 10, 2015 | Sale | $4.55 | 29,000 | 131,985 | 122,345 | Jul 10, 2015, 06:57 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Jul 09, 2015 | Sale | $4.55 | 4,400 | 20,020 | 122,345 | Jul 10, 2015, 06:57 PM |
| Varian John | CEO | Jun 15, 2015 | Option Exercise | $1.24 | 10,000 | 12,400 | 562,414 | Jun 17, 2015, 03:41 PM |
| Varian John | CEO | Jun 15, 2015 | Sale | $3.64 | 10,000 | 36,362 | 552,414 | Jun 17, 2015, 03:41 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | May 28, 2015 | Sale | $3.60 | 1,788 | 6,437 | 122,345 | Jun 01, 2015, 06:24 PM |
| Varian John | CEO | May 15, 2015 | Option Exercise | $1.24 | 10,000 | 12,400 | 562,414 | May 19, 2015, 06:08 PM |
| Varian John | CEO | May 15, 2015 | Sale | $3.34 | 10,000 | 33,400 | 552,414 | May 19, 2015, 06:08 PM |
| Varian John | CEO | Apr 15, 2015 | Option Exercise | $1.24 | 10,000 | 12,400 | 562,414 | Apr 15, 2015, 06:50 PM |
| Varian John | CEO | Apr 15, 2015 | Sale | $3.86 | 10,000 | 38,606 | 552,414 | Apr 15, 2015, 06:50 PM |
| KURLAND FRED | CFO & VP Finance | Apr 06, 2015 | Option Exercise | $3.61 | 35,275 | 127,251 | 97,445 | Apr 07, 2015, 07:20 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Mar 23, 2015 | Sale | $3.94 | 32,742 | 128,879 | 119,467 | Mar 23, 2015, 06:35 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Mar 18, 2015 | Option Exercise | $4.01 | 8,666 | 34,755 | 121,353 | Mar 20, 2015, 07:30 PM |
| Klein Thomas | Chief Commercial Officer | Mar 18, 2015 | Option Exercise | $4.01 | 53,037 | 212,705 | 238,344 | Mar 20, 2015, 07:30 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Mar 18, 2015 | Option Exercise | $4.01 | 20,535 | 82,356 | 163,906 | Mar 20, 2015, 07:30 PM |
| Neal James R | Mar 18, 2015 | Option Exercise | $4.01 | 9,019 | 36,171 | 189,967 | Mar 20, 2015, 07:30 PM | |
| KURLAND FRED | CFO & VP Finance | Mar 18, 2015 | Option Exercise | $4.01 | 9,163 | 36,748 | 75,156 | Mar 20, 2015, 07:30 PM |
| Varian John | CEO | Mar 18, 2015 | Option Exercise | $4.01 | 44,877 | 179,979 | 575,875 | Mar 20, 2015, 07:30 PM |
| Varian John | CEO | Mar 16, 2015 | Option Exercise | $1.24 | 10,000 | 12,400 | 570,384 | Mar 17, 2015, 06:52 PM |
| Varian John | CEO | Mar 16, 2015 | Sale | $3.72 | 10,000 | 37,223 | 560,384 | Mar 17, 2015, 06:52 PM |
| Varian John | CEO | Feb 17, 2015 | Option Exercise | $1.24 | 10,000 | 12,400 | 377,184 | Feb 19, 2015, 06:09 PM |
| Varian John | CEO | Feb 17, 2015 | Sale | $3.52 | 10,000 | 35,192 | 367,184 | Feb 19, 2015, 06:09 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Feb 02, 2015 | Sale | $3.52 | 5,000 | 17,622 | 76,346 | Feb 03, 2015, 01:38 PM |
| Varian John | CEO | Jan 15, 2015 | Option Exercise | $1.24 | 10,000 | 12,400 | 377,184 | Jan 16, 2015, 05:22 PM |
| Varian John | CEO | Jan 15, 2015 | Sale | $3.46 | 10,000 | 34,582 | 367,184 | Jan 16, 2015, 05:22 PM |
| BAKER BROS. ADVISORS LP | Director | Jan 06, 2015 | Sale | $3.86 | 1,000,000 | 3,860,000 | 12,589,950 | Jan 06, 2015, 08:31 PM |
| BAKER BROS. ADVISORS LP | Director | Jan 05, 2015 | Sale | $3.81 | 1,003,300 | 3,824,078 | 13,449,938 | Jan 06, 2015, 08:31 PM |
| BAKER BROS. ADVISORS LP | Director | Jan 02, 2015 | Sale | $3.55 | 212,100 | 753,740 | 14,313,038 | Jan 06, 2015, 08:31 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Jan 02, 2015 | Sale | $3.55 | 5,000 | 17,756 | 81,346 | Jan 05, 2015, 05:32 PM |
| BAKER BROS. ADVISORS LP | Director | Dec 29, 2014 | Sale | $3.68 | 221,000 | 812,440 | 14,832,615 | Dec 30, 2014, 05:40 PM |
| BAKER BROS. ADVISORS LP | Director | Dec 26, 2014 | Sale | $3.71 | 131,100 | 486,460 | 15,022,732 | Dec 30, 2014, 05:40 PM |
| BAKER BROS. ADVISORS LP | Director | Dec 30, 2014 | Sale | $3.65 | 391,900 | 1,430,239 | 14,495,492 | Dec 30, 2014, 05:40 PM |
| BAKER BROS. ADVISORS LP | Director | Dec 19, 2014 | Sale | $4.21 | 752,900 | 3,168,580 | 15,135,587 | Dec 19, 2014, 05:13 PM |
| BAKER BROS. ADVISORS LP | Director | Dec 18, 2014 | Sale | $4.29 | 165,700 | 710,687 | 15,783,368 | Dec 19, 2014, 05:13 PM |
| BAKER BROS. ADVISORS LP | Director | Dec 17, 2014 | Sale | $4.31 | 686,500 | 2,958,129 | 15,925,911 | Dec 19, 2014, 05:13 PM |
| BAKER BROS. ADVISORS LP | Director | Dec 12, 2014 | Sale | $4.71 | 253,800 | 1,196,413 | 17,187,779 | Dec 16, 2014, 05:29 PM |
| BAKER BROS. ADVISORS LP | Director | Dec 16, 2014 | Sale | $4.27 | 319,200 | 1,363,271 | 16,516,549 | Dec 16, 2014, 05:29 PM |
| BAKER BROS. ADVISORS LP | Director | Dec 15, 2014 | Sale | $4.45 | 460,800 | 2,050,652 | 16,791,283 | Dec 16, 2014, 05:29 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Dec 15, 2014 | Option Exercise | $3.04 | 1,600 | 4,864 | 73,621 | Dec 16, 2014, 01:01 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Dec 15, 2014 | Sale | $4.63 | 1,600 | 7,401 | 72,021 | Dec 16, 2014, 01:01 PM |
| Varian John | CEO | Dec 15, 2014 | Option Exercise | $1.24 | 10,000 | 12,400 | 377,184 | Dec 16, 2014, 01:01 PM |
| Varian John | CEO | Dec 15, 2014 | Sale | $4.49 | 10,000 | 44,929 | 367,184 | Dec 16, 2014, 01:01 PM |
| BAKER BROS. ADVISORS LP | Director | Dec 09, 2014 | Sale | $4.62 | 392,353 | 1,811,062 | 17,406,162 | Dec 10, 2014, 05:50 PM |
| BAKER BROS. ADVISORS LP | Director | Dec 04, 2014 | Sale | $4.55 | 1,304,288 | 5,928,902 | 17,743,703 | Dec 04, 2014, 06:05 PM |
| BAKER BROS. ADVISORS LP | Director | Dec 03, 2014 | Sale | $4.84 | 567,918 | 2,748,837 | 18,866,287 | Dec 04, 2014, 06:05 PM |
| BAKER BROS. ADVISORS LP | Director | Dec 02, 2014 | Sale | $5.36 | 500,000 | 2,679,550 | 19,353,087 | Dec 04, 2014, 06:05 PM |
| Neal James R | VP Business Development | Nov 26, 2014 | Sale | $5.67 | 1,678 | 9,514 | 137,760 | Dec 01, 2014, 05:29 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Dec 01, 2014 | Sale | $5.51 | 5,000 | 27,569 | 86,346 | Dec 01, 2014, 05:28 PM |
| Neal James R | VP Business Development | Nov 24, 2014 | Sale | $5.03 | 1,032 | 5,193 | 139,438 | Nov 24, 2014, 06:25 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Nov 20, 2014 | Option Exercise | $3.04 | 5,000 | 15,200 | 77,021 | Nov 21, 2014, 02:46 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Nov 20, 2014 | Sale | $4.55 | 5,000 | 22,750 | 72,021 | Nov 21, 2014, 02:46 PM |
| KURLAND FRED | CFO & VP Finance | Nov 13, 2014 | Sale | $3.89 | 8,773 | 34,148 | 85,086 | Nov 17, 2014, 05:45 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Nov 13, 2014 | Sale | $3.89 | 8,245 | 32,093 | 91,346 | Nov 17, 2014, 05:45 PM |
| Varian John | CEO | Nov 13, 2014 | Sale | $3.89 | 2,630 | 10,237 | 367,184 | Nov 17, 2014, 05:44 PM |
| Varian John | CEO | Nov 13, 2013 | Sale | $3.89 | 56,214 | 218,807 | 92,525 | Nov 17, 2014, 05:44 PM |
| Neal James R | VP Business Development | Nov 13, 2014 | Sale | $3.89 | 4,387 | 17,076 | 140,470 | Nov 17, 2014, 05:44 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Nov 03, 2014 | Sale | $4.33 | 5,000 | 21,660 | 76,939 | Nov 03, 2014, 07:37 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Oct 28, 2014 | Option Exercise | $3.04 | 5,000 | 15,200 | 77,021 | Oct 29, 2014, 03:11 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Oct 28, 2014 | Sale | $4.57 | 5,000 | 22,829 | 72,021 | Oct 29, 2014, 03:11 PM |
| Varian John | CEO | Oct 15, 2014 | Option Exercise | $1.24 | 10,000 | 12,400 | 335,364 | Oct 15, 2014, 06:20 PM |
| Varian John | CEO | Oct 15, 2014 | Sale | $3.87 | 10,000 | 38,690 | 325,364 | Oct 15, 2014, 06:20 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Oct 01, 2014 | Sale | $4.09 | 5,000 | 20,447 | 81,939 | Oct 01, 2014, 06:15 PM |
| Varian John | CEO | Sep 15, 2014 | Option Exercise | $1.24 | 10,000 | 12,400 | 335,364 | Sep 16, 2014, 04:41 PM |
| Varian John | CEO | Sep 15, 2014 | Sale | $4.56 | 10,000 | 45,577 | 325,364 | Sep 16, 2014, 04:41 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Sep 15, 2014 | Option Exercise | $3.04 | 5,000 | 15,200 | 77,021 | Sep 16, 2014, 04:41 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Sep 15, 2014 | Sale | $4.59 | 5,000 | 22,938 | 72,021 | Sep 16, 2014, 04:41 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Sep 04, 2014 | Option Exercise | $3.04 | 10,000 | 30,400 | 82,021 | Sep 08, 2014, 05:17 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Sep 04, 2014 | Sale | $4.56 | 10,000 | 45,640 | 72,021 | Sep 08, 2014, 05:17 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Sep 02, 2014 | Sale | $4.31 | 5,000 | 21,553 | 86,939 | Sep 03, 2014, 02:42 PM |
| KURLAND FRED | CFO & VP Finance | Aug 15, 2014 | Sale | $4.31 | 10,401 | 44,780 | 71,263 | Aug 19, 2014, 12:47 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Aug 18, 2014 | Sale | $4.36 | 16,449 | 71,752 | 72,021 | Aug 19, 2014, 12:47 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Aug 15, 2014 | Sale | $4.31 | 10,299 | 44,341 | 88,470 | Aug 19, 2014, 12:47 PM |
| Neal James R | VP Business Development | Aug 15, 2014 | Sale | $4.61 | 6,584 | 30,322 | 144,857 | Aug 18, 2014, 06:21 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Aug 15, 2014 | Sale | $4.31 | 5,871 | 25,277 | 91,939 | Aug 18, 2014, 06:21 PM |
| Varian John | CEO | Aug 15, 2014 | Option Exercise | $1.24 | 10,000 | 12,400 | 335,364 | Aug 18, 2014, 06:21 PM |
| Varian John | CEO | Aug 15, 2014 | Sale | $4.30 | 64,823 | 279,035 | 325,364 | Aug 18, 2014, 06:21 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Aug 01, 2014 | Sale | $3.83 | 5,000 | 19,161 | 81,546 | Aug 04, 2014, 06:53 PM |
| Varian John | CEO | Jul 15, 2014 | Option Exercise | $1.24 | 10,000 | 12,400 | 295,613 | Jul 16, 2014, 05:18 PM |
| Varian John | CEO | Jul 15, 2014 | Sale | $4.03 | 10,000 | 40,285 | 285,613 | Jul 16, 2014, 05:18 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Jul 01, 2014 | Sale | $4.68 | 5,000 | 23,411 | 86,546 | Jul 02, 2014, 04:28 PM |
| Varian John | CEO | Jun 16, 2014 | Option Exercise | $1.24 | 10,000 | 12,400 | 295,613 | Jun 18, 2014, 05:14 PM |
| Varian John | CEO | Jun 16, 2014 | Sale | $4.54 | 10,000 | 45,410 | 285,613 | Jun 18, 2014, 05:14 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Jun 16, 2014 | Sale | $4.54 | 11,580 | 52,595 | 72,021 | Jun 18, 2014, 05:14 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | May 28, 2014 | Sale | $4.22 | 1,785 | 7,533 | 83,601 | May 29, 2014, 05:48 PM |
| Varian John | CEO | May 15, 2014 | Option Exercise | $1.24 | 10,000 | 12,400 | 295,613 | May 15, 2014, 05:49 PM |
| Varian John | CEO | May 15, 2014 | Sale | $3.55 | 10,000 | 35,515 | 285,613 | May 15, 2014, 05:49 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | May 13, 2014 | Sale | $3.84 | 10,000 | 38,404 | 80,719 | May 15, 2014, 03:16 PM |
| Varian John | CEO | Apr 15, 2014 | Option Exercise | $1.24 | 10,000 | 12,400 | 295,613 | Apr 17, 2014, 04:28 PM |
| Varian John | CEO | Apr 15, 2014 | Sale | $4.06 | 10,000 | 40,645 | 285,613 | Apr 17, 2014, 04:28 PM |
| KURLAND FRED | CFO & VP Finance | Mar 18, 2014 | Sale | $6.32 | 5,915 | 37,359 | 62,600 | Mar 20, 2014, 03:39 PM |
| Varian John | CEO | Mar 18, 2014 | Sale | $6.32 | 21,329 | 134,714 | 285,613 | Mar 20, 2014, 03:39 PM |
| Neal James R | VP Business Development | Mar 18, 2014 | Sale | $6.32 | 2,671 | 16,870 | 151,441 | Mar 20, 2014, 03:39 PM |
| Klein Thomas | Chief Commercial Officer | Mar 18, 2014 | Sale | $6.32 | 30,965 | 195,575 | 93,150 | Mar 20, 2014, 03:38 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Mar 18, 2014 | Sale | $6.32 | 3,419 | 21,594 | 91,546 | Mar 20, 2014, 03:38 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Mar 18, 2014 | Option Exercise | $3.04 | 6,000 | 18,240 | 96,719 | Mar 20, 2014, 03:38 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Mar 18, 2014 | Sale | $6.31 | 17,649 | 111,423 | 90,719 | Mar 20, 2014, 03:38 PM |
| Varian John | CEO | Mar 17, 2014 | Option Exercise | $1.24 | 10,000 | 12,400 | 280,035 | Mar 18, 2014, 01:42 PM |
| Varian John | CEO | Mar 17, 2014 | Sale | $6.03 | 10,000 | 60,292 | 270,035 | Mar 18, 2014, 01:42 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Feb 18, 2014 | Option Exercise | $3.04 | 6,000 | 18,240 | 9,228 | Feb 19, 2014, 04:36 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Feb 18, 2014 | Sale | $7.55 | 6,000 | 45,272 | 3,228 | Feb 19, 2014, 04:36 PM |
| Varian John | CEO | Feb 18, 2014 | Option Exercise | $1.24 | 10,000 | 12,400 | 158,739 | Feb 19, 2014, 04:36 PM |
| Varian John | CEO | Feb 18, 2014 | Sale | $7.55 | 10,000 | 75,478 | 148,739 | Feb 19, 2014, 04:36 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Jan 21, 2014 | Option Exercise | $3.04 | 5,694 | 17,310 | 8,922 | Jan 23, 2014, 05:25 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Jan 21, 2014 | Sale | $8.27 | 6,000 | 49,608 | 3,228 | Jan 23, 2014, 05:25 PM |
| Varian John | CEO | Jan 15, 2014 | Option Exercise | $1.24 | 10,000 | 12,400 | 158,739 | Jan 17, 2014, 12:19 PM |
| Varian John | CEO | Jan 15, 2014 | Sale | $8.28 | 10,000 | 82,791 | 148,739 | Jan 17, 2014, 12:19 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Jan 09, 2014 | Option Exercise | $1.69 | 20,000 | 33,800 | 62,017 | Jan 10, 2014, 03:00 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Jan 09, 2014 | Sale | $8.00 | 20,000 | 160,042 | 42,017 | Jan 10, 2014, 03:00 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Dec 18, 2013 | Option Exercise | $3.04 | 6,000 | 18,240 | 9,534 | Dec 18, 2013, 06:54 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Dec 18, 2013 | Sale | $5.67 | 6,000 | 33,992 | 3,534 | Dec 18, 2013, 06:54 PM |
| Varian John | CEO | Dec 16, 2013 | Option Exercise | $1.24 | 20,000 | 24,800 | 158,739 | Dec 18, 2013, 04:41 PM |
| Varian John | CEO | Dec 16, 2013 | Sale | $5.44 | 20,000 | 108,744 | 148,739 | Dec 18, 2013, 04:41 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Dec 02, 2013 | Option Exercise | $1.69 | 20,000 | 33,800 | 58,682 | Dec 03, 2013, 04:22 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Dec 02, 2013 | Sale | $6.00 | 20,000 | 120,002 | 42,017 | Dec 03, 2013, 04:22 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Nov 27, 2013 | Option Exercise | $3.04 | 4,696 | 14,276 | 8,230 | Dec 02, 2013, 01:19 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Nov 27, 2013 | Sale | $4.54 | 4,696 | 21,320 | 3,534 | Dec 02, 2013, 01:19 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Nov 18, 2013 | Option Exercise | $2.36 | 1,304 | 3,077 | 4,838 | Nov 19, 2013, 03:20 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Nov 18, 2013 | Sale | $4.08 | 1,304 | 5,317 | 3,534 | Nov 19, 2013, 03:20 PM |
| Varian John | CEO | Nov 15, 2013 | Option Exercise | $1.24 | 10,000 | 12,400 | 158,739 | Nov 15, 2013, 07:05 PM |
| Varian John | CEO | Nov 15, 2013 | Sale | $4.13 | 10,000 | 41,329 | 148,739 | Nov 15, 2013, 07:05 PM |
| Varian John | CEO | Nov 13, 2013 | Sale | $3.91 | 54,932 | 214,938 | 148,739 | Nov 15, 2013, 07:05 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Nov 13, 2013 | Sale | $3.91 | 8,346 | 32,660 | 42,017 | Nov 15, 2013, 06:51 PM |
| KURLAND FRED | CFO & VP Finance | Nov 13, 2013 | Sale | $3.91 | 12,331 | 48,244 | 22,085 | Nov 15, 2013, 06:48 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Oct 18, 2013 | Sale | $4.71 | 5,254 | 24,725 | 3,534 | Nov 01, 2013, 05:33 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Oct 18, 2013 | Option Exercise | $2.36 | 746 | 1,761 | 9,534 | Oct 21, 2013, 04:54 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Oct 18, 2013 | Sale | $4.71 | 746 | 3,511 | 8,788 | Oct 21, 2013, 04:54 PM |
| Varian John | Director and CEO | Oct 15, 2013 | Option Exercise | $1.24 | 10,000 | 12,400 | 113,006 | Oct 16, 2013, 04:44 PM |
| Varian John | Director and CEO | Oct 15, 2013 | Sale | $4.59 | 10,000 | 45,950 | 103,006 | Oct 16, 2013, 04:44 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Sep 30, 2013 | Option Exercise | $4.27 | 459 | 1,958 | 8,788 | Oct 02, 2013, 05:29 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Sep 18, 2013 | Sale | $4.53 | 6,000 | 27,187 | 8,329 | Sep 19, 2013, 05:50 PM |
| Varian John | Director and CEO | Sep 16, 2013 | Option Exercise | $1.24 | 10,000 | 12,400 | 113,006 | Sep 17, 2013, 05:48 PM |
| Varian John | Director and CEO | Sep 16, 2013 | Sale | $4.59 | 10,000 | 45,862 | 103,006 | Sep 17, 2013, 05:48 PM |
| BAKER BROS. ADVISORS LP | Director | Aug 19, 2013 | Buy | $3.62 | 2,757,791 | 9,983,203 | 19,767,770 | Aug 21, 2013, 07:54 PM |
| BAKER BROS. ADVISORS LP | Director | Aug 19, 2013 | Option Exercise | $3.62 | 2,757,791 | 9,983,203 | 19,767,770 | Aug 21, 2013, 05:07 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Aug 19, 2013 | Sale | $3.74 | 6,000 | 22,419 | 14,329 | Aug 19, 2013, 06:37 PM |
| Varian John | Director and CEO | Aug 15, 2013 | Option Exercise | $1.24 | 10,000 | 12,400 | 113,006 | Aug 16, 2013, 07:57 PM |
| Varian John | Director and CEO | Aug 14, 2013 | Sale | $3.86 | 51,647 | 199,419 | 8,432 | Aug 16, 2013, 07:57 PM |
| Varian John | Director and CEO | Aug 15, 2013 | Sale | $3.92 | 10,000 | 39,212 | 103,006 | Aug 16, 2013, 07:57 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Aug 14, 2013 | Sale | $3.86 | 10,520 | 40,621 | 20,329 | Aug 16, 2013, 07:49 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Aug 14, 2013 | Sale | $3.86 | 6,002 | 23,175 | 27,711 | Aug 16, 2013, 07:42 PM |
| KURLAND FRED | CFO & VP Finance | Aug 14, 2013 | Sale | $3.86 | 7,498 | 28,951 | 25,051 | Aug 16, 2013, 07:34 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Jul 18, 2013 | Option Exercise | $2.73 | 6,000 | 16,371 | 7,353 | Jul 19, 2013, 02:59 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Jul 18, 2013 | Sale | $4.71 | 6,000 | 28,233 | 4,101 | Jul 19, 2013, 02:59 PM |
| Varian John | Director and CEO | Jul 15, 2013 | Option Exercise | $1.24 | 10,000 | 12,400 | 70,079 | Jul 17, 2013, 03:49 PM |
| Varian John | Director and CEO | Jul 15, 2013 | Sale | $4.81 | 10,000 | 48,066 | 60,079 | Jul 17, 2013, 03:49 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Jun 28, 2013 | Option Exercise | $3.45 | 567 | 1,955 | 4,101 | Jul 01, 2013, 04:24 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Jun 18, 2013 | Option Exercise | $2.36 | 3,130 | 7,387 | 9,534 | Jun 18, 2013, 07:48 PM |
| Varian John | Director and CEO | Jun 17, 2013 | Option Exercise | $1.24 | 10,000 | 12,400 | 70,079 | Jun 18, 2013, 07:33 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | Jun 11, 2013 | Option Exercise | $1.69 | 10,000 | 16,900 | 27,448 | Jun 12, 2013, 04:13 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | May 29, 2013 | Sale | $4.16 | 1,797 | 7,476 | 6,404 | May 29, 2013, 06:46 PM |
| WYSZOMIERSKI JACK L | Director | May 28, 2013 | Option Exercise | $2.69 | 2,800 | 7,532 | 7,299 | May 29, 2013, 04:20 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | May 20, 2013 | Option Exercise | $2.36 | 785 | 1,853 | 9,534 | May 21, 2013, 07:24 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | May 20, 2013 | Sale | $4.16 | 785 | 3,266 | 8,749 | May 21, 2013, 07:24 PM |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | May 14, 2013 | Option Exercise | $1.69 | 10,000 | 16,900 | 27,448 | May 15, 2013, 07:19 PM |
| Varian John | Director and CEO | May 15, 2013 | Option Exercise | $1.24 | 10,000 | 12,400 | 70,079 | May 15, 2013, 07:15 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Mar 28, 2013 | Option Exercise | $3.32 | 1,498 | 4,967 | 14,749 | Apr 01, 2013, 04:59 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Mar 19, 2013 | Sale | $3.29 | 6,990 | 22,997 | 13,251 | Mar 27, 2013, 05:31 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Dec 31, 2012 | Option Exercise | $2.28 | 833 | 1,899 | 2,036 | Jan 02, 2013, 04:57 PM |
| Varian John | Director and CEO | Nov 14, 2012 | Sale | $2.56 | 40,587 | 103,807 | 98,852 | Nov 15, 2012, 10:01 AM |
| SCANNON PATRICK J MD PHD | Executive Vice President | Nov 14, 2012 | Sale | $2.56 | 8,773 | 22,445 | 17,448 | Nov 15, 2012, 10:01 AM |
| KURLAND FRED | CFO & VP Finance | Nov 14, 2012 | Sale | $2.56 | 9,111 | 23,310 | 13,485 | Nov 15, 2012, 10:01 AM |
| BAKER JULIAN | Director | Oct 29, 2012 | Buy | $3.00 | 4,722,666 | 14,167,998 | 17,888,512 | Oct 31, 2012, 05:02 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Sep 28, 2012 | Option Exercise | $3.51 | 542 | 1,900 | 1,203 | Oct 01, 2012, 06:02 PM |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | Jun 29, 2012 | Option Exercise | $2.83 | 661 | 1,871 | 661 | Jul 02, 2012, 05:52 PM |
| RUBIN PAUL D | VP Clinical Dev. & CMO | Mar 30, 2012 | Option Exercise | $2.63 | 1,229 | 3,234 | 3,887 | Apr 02, 2012, 04:09 PM |
| VAN NESS W DENMAN | Director | Nov 11, 2011 | Sale | $1.60 | 698 | 1,117 | 2,600 | Nov 16, 2011, 02:56 PM |
| RUBIN PAUL D | VP Clinical Dev. & CMO | Sep 30, 2011 | Option Exercise | $1.66 | 1,022 | 1,699 | 1,022 | Oct 03, 2011, 04:52 PM |
| KURLAND FRED | CFO & VP Finance | Mar 25, 2011 | Buy | $3.26 | 5,000 | 16,320 | 5,000 | Mar 28, 2011, 05:47 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| Sitko Bradley | Chief Investment Officer | 10/02/2023 | 21,375 |
| Sitko Bradley | Chief Investment Officer | 10/03/2023 | 3,473 |
| Hughes Owen | Exec Chairman and Interim CEO | 10/02/2023 | 13,830 |
| Hughes Owen | Exec Chairman and Interim CEO | 09/26/2023 | 36,061 |
| Hughes Owen | Exec Chairman and Interim CEO | 09/25/2023 | 15 |
| Sitko Bradley | Chief Investment Officer | 05/31/2023 | 25,700 |
| Sitko Bradley | Chief Investment Officer | 05/23/2023 | 16,150 |
| Hughes Owen | Interim CEO | 05/23/2023 | 22,706 |
| Hughes Owen | Interim CEO | 05/24/2023 | 24,551 |
| Sitko Bradley | Chief Investment Officer | 05/19/2023 | 19,500 |
| Sitko Bradley | Chief Investment Officer | 05/16/2023 | 11,602 |
| Sitko Bradley | Chief Investment Officer | 05/15/2023 | 35,100 |
| Sitko Bradley | Chief Investment Officer | 05/12/2023 | 37,985 |
| BVF PARTNERS L P/IL | Director | 01/06/2023 | 71,419 |
| BVF PARTNERS L P/IL | Director | 01/05/2023 | 349,319 |
| BVF PARTNERS L P/IL | Director | 09/27/2022 | 28,409 |
| BVF PARTNERS L P/IL | Director | 09/26/2022 | 107,050 |
| BVF PARTNERS L P/IL | Director | 09/23/2022 | 273,850 |
| BVF PARTNERS L P/IL | Director | 09/16/2022 | 434,536 |
| BVF PARTNERS L P/IL | Director | 09/15/2022 | 100,138 |
| BVF PARTNERS L P/IL | Director | 09/14/2022 | 456,044 |
| BURNS THOMAS M. | SVP, Finance & CFO | 07/15/2022 | 8,060 |
| BURNS THOMAS M. | SVP, Finance & CFO | 07/15/2022 | 63,321 |
| Neal James R | CEO | 07/15/2022 | 100,750 |
| Neal James R | CEO | 07/15/2022 | 746,104 |
| Neal James R | CEO | 03/22/2022 | 9,426 |
| Neal James R | CEO | 03/21/2022 | 201,500 |
| Neal James R | CEO | 03/23/2022 | 4,477 |
| Neal James R | CEO | 03/21/2022 | 1,450,250 |
| Neal James R | CEO | 03/23/2022 | 33,348 |
| Neal James R | CEO | 03/22/2022 | 70,209 |
| BURNS THOMAS M. | SVP, Finance & CFO | 03/21/2022 | 48,360 |
| BURNS THOMAS M. | SVP, Finance & CFO | 03/23/2022 | 649 |
| BURNS THOMAS M. | SVP, Finance & CFO | 03/22/2022 | 9,426 |
| BURNS THOMAS M. | SVP, Finance & CFO | 03/21/2022 | 348,060 |
| BURNS THOMAS M. | SVP, Finance & CFO | 03/23/2022 | 4,830 |
| BURNS THOMAS M. | SVP, Finance & CFO | 03/22/2022 | 70,209 |
| Neal James R | CEO | 04/09/2021 | 200,000 |
| BURNS THOMAS M. | SVP, Finance & CFO | 04/09/2021 | 25,000 |
| VAN NESS W DENMAN | Director | 03/15/2021 | 59,332 |
| Neal James R | CEO | 12/15/2020 | 200,000 |
| Neal James R | CEO | 12/15/2020 | 143,000 |
| Neal James R | CEO | 12/15/2020 | 1,074,998 |
| BURNS THOMAS M. | SVP, Finance & CFO | 12/15/2020 | 50,000 |
| BURNS THOMAS M. | SVP, Finance & CFO | 12/15/2020 | 60,450 |
| BURNS THOMAS M. | SVP, Finance & CFO | 12/15/2020 | 621,086 |
| Hernday Natasha | Director | 12/15/2020 | 100,000 |
| PERRY MATTHEW D | Director | 12/11/2020 | 5,000,000 |
| BVF PARTNERS L P/IL | Director | 12/11/2020 | 5,000,000 |
| Neal James R | CEO | 11/23/2020 | 72,193 |
| Neal James R | CEO | 11/20/2020 | 37,807 |
| BURNS THOMAS M. | SVP, Finance & CFO | 11/23/2020 | 20,654 |
| BURNS THOMAS M. | SVP, Finance & CFO | 11/20/2020 | 27,706 |
| Neal James R | CEO | 11/20/2020 | 223,523 |
| BURNS THOMAS M. | SVP, Finance & CFO | 11/23/2020 | 168,752 |
| BURNS THOMAS M. | SVP, Finance & CFO | 11/20/2020 | 223,555 |
| Neal James R | CEO | 11/23/2020 | 432,662 |
| Neal James R | CEO | 11/05/2020 | 55,000 |
| Neal James R | CEO | 11/05/2020 | 260,205 |
| BURNS THOMAS M. | SVP, Finance & CFO | 11/05/2020 | 32,240 |
| BURNS THOMAS M. | SVP, Finance & CFO | 11/05/2020 | 208,908 |
| BVF PARTNERS L P/IL | Director | 09/23/2020 | 311,016 |
| BVF PARTNERS L P/IL | Director | 09/22/2020 | 220,445 |
| BVF PARTNERS L P/IL | Director | 09/21/2020 | 410,502 |
| BVF PARTNERS L P/IL | Director | 09/04/2020 | 145,228 |
| BVF PARTNERS L P/IL | Director | 08/28/2020 | 39,187 |
| BVF PARTNERS L P/IL | Director | 09/01/2020 | 331,515 |
| BVF PARTNERS L P/IL | Director | 08/31/2020 | 295,782 |
| BVF PARTNERS L P/IL | Director | 08/25/2020 | 112,290 |
| BVF PARTNERS L P/IL | Director | 08/24/2020 | 225,591 |
| BVF PARTNERS L P/IL | Director | 08/21/2020 | 208,770 |
| BVF PARTNERS L P/IL | 10% Owner | 08/18/2020 | 17,246 |
| BVF PARTNERS L P/IL | 10% Owner | 08/20/2020 | 33,881 |
| BVF PARTNERS L P/IL | 10% Owner | 08/19/2020 | 68,877 |
| BVF PARTNERS L P/IL | 10% Owner | 08/14/2020 | 409,810 |
| BVF PARTNERS L P/IL | 10% Owner | 08/13/2020 | 18,693 |
| BVF PARTNERS L P/IL | 10% Owner | 08/12/2020 | 70,233 |
| BVF PARTNERS L P/IL | 10% Owner | 04/15/2020 | 16,286,036 |
| BVF PARTNERS L P/IL | 10% Owner | 03/25/2020 | 142,129 |
| Neal James R | CEO | 03/23/2020 | 14,500 |
| Neal James R | CEO | 03/20/2020 | 16,410 |
| BVF PARTNERS L P/IL | 10% Owner | 03/18/2020 | 64,475 |
| BVF PARTNERS L P/IL | 10% Owner | 03/17/2020 | 127,648 |
| BVF PARTNERS L P/IL | 10% Owner | 03/16/2020 | 159,916 |
| BVF PARTNERS L P/IL | 10% Owner | 03/13/2020 | 1,834,090 |
| Neal James R | CEO | 12/23/2019 | 25,960 |
| BVF PARTNERS L P/IL | 10% Owner | 12/19/2019 | 8,210,290 |
| BVF PARTNERS L P/IL | 10% Owner | 12/18/2019 | 10,389,896 |
| Neal James R | CEO | 11/06/2019 | 23,914 |
| Neal James R | CEO | 11/06/2019 | 95,656 |
| Neal James R | Chief Executive Officer | 09/18/2019 | 21,065 |
| Neal James R | Chief Executive Officer | 09/20/2019 | 29,986 |
| Neal James R | Chief Executive Officer | 09/19/2019 | 35,035 |
| Neal James R | Chief Executive Officer | 09/20/2019 | 110,271 |
| Neal James R | Chief Executive Officer | 09/19/2019 | 134,544 |
| Neal James R | Chief Executive Officer | 09/18/2019 | 84,113 |
| BURNS THOMAS M. | Sr. VP, Finance and CFO | 09/18/2019 | 15,431 |
| BURNS THOMAS M. | Sr. VP, Finance and CFO | 09/19/2019 | 16,809 |
| BURNS THOMAS M. | Sr. VP, Finance and CFO | 09/19/2019 | 89,296 |
| BURNS THOMAS M. | Sr. VP, Finance and CFO | 09/18/2019 | 84,091 |
| BVF PARTNERS L P/IL | 10% Owner | 05/14/2019 | 203,664 |
| BVF PARTNERS L P/IL | 10% Owner | 05/13/2019 | 54,526 |
| BVF PARTNERS L P/IL | 10% Owner | 05/10/2019 | 150,037 |
| VAN NESS W DENMAN | Director | 05/10/2019 | 1,912 |
| Neal James R | CEO | 12/20/2018 | 8,814 |
| VAN NESS W DENMAN | Director | 12/20/2018 | 10,400 |
| BVF PARTNERS L P/IL | 10% Owner | 12/17/2018 | 354,792 |
| BVF PARTNERS L P/IL | 10% Owner | 12/13/2018 | 349,525 |
| BVF PARTNERS L P/IL | 10% Owner | 12/12/2018 | 41,448 |
| BVF PARTNERS L P/IL | 10% Owner | 12/11/2018 | 136,270 |
| BVF PARTNERS L P/IL | 10% Owner | 12/06/2018 | 161,698 |
| BVF PARTNERS L P/IL | 10% Owner | 12/10/2018 | 262,972 |
| BVF PARTNERS L P/IL | 10% Owner | 12/07/2018 | 472,778 |
| BVF PARTNERS L P/IL | 10% Owner | 12/04/2018 | 62,515 |
| BVF PARTNERS L P/IL | 10% Owner | 12/03/2018 | 12,009 |
| BVF PARTNERS L P/IL | 10% Owner | 11/30/2018 | 71,615 |
| BVF PARTNERS L P/IL | 10% Owner | 11/29/2018 | 149,543 |
| BVF PARTNERS L P/IL | 10% Owner | 11/28/2018 | 125,262 |
| BVF PARTNERS L P/IL | 10% Owner | 11/27/2018 | 173,680 |
| BVF PARTNERS L P/IL | 10% Owner | 11/21/2018 | 374,892 |
| BVF PARTNERS L P/IL | 10% Owner | 11/20/2018 | 512,701 |
| BVF PARTNERS L P/IL | 10% Owner | 11/19/2018 | 136,064 |
| BVF PARTNERS L P/IL | 10% Owner | 11/16/2018 | 149,986 |
| BVF PARTNERS L P/IL | 10% Owner | 11/15/2018 | 281,361 |
| VAN NESS W DENMAN | Director | 11/15/2018 | 52,699 |
| VAN NESS W DENMAN | Director | 11/15/2018 | 70,040 |
| Neal James R | CEO | 11/13/2018 | 53,056 |
| BURNS THOMAS M. | SVP, Finance & CFO | 04/27/2018 | 14,603 |
| BURNS THOMAS M. | SVP, Finance & CFO | 04/26/2018 | 45,898 |
| BURNS THOMAS M. | SVP, Finance & CFO | 04/27/2018 | 65,757 |
| BURNS THOMAS M. | SVP, Finance & CFO | 04/26/2018 | 206,050 |
| Neal James R | CEO | 04/27/2018 | 86,103 |
| Neal James R | CEO | 04/26/2018 | 45,898 |
| Neal James R | CEO | 04/27/2018 | 382,236 |
| Neal James R | CEO | 04/26/2018 | 206,050 |
| Neal James R | CEO | 11/14/2017 | 34,589 |
| Neal James R | CEO | 11/13/2017 | 46,619 |
| Neal James R | CEO | 11/15/2017 | 105,364 |
| Neal James R | CEO | 11/13/2017 | 356,674 |
| Neal James R | CEO | 11/15/2017 | 706,766 |
| Neal James R | CEO | 11/14/2017 | 243,747 |
| BURNS THOMAS M. | SVP, Finance & CFO | 11/14/2017 | 27,593 |
| BURNS THOMAS M. | SVP, Finance & CFO | 11/13/2017 | 28,141 |
| BURNS THOMAS M. | SVP, Finance & CFO | 11/15/2017 | 33,820 |
| BURNS THOMAS M. | SVP, Finance & CFO | 11/13/2017 | 216,419 |
| BURNS THOMAS M. | SVP, Finance & CFO | 11/15/2017 | 226,978 |
| BURNS THOMAS M. | SVP, Finance & CFO | 11/14/2017 | 194,053 |
| Varian John | Director | 05/16/2017 | 246,919 |
| Neal James R | VP Business Development | 03/21/2017 | 27,569 |
| BURNS THOMAS M. | VP, Finance & Chief Financial | 03/21/2017 | 14,030 |
| Neal James R | VP Business Development | 02/01/2017 | 881 |
| Neal James R | VP Business Development | 01/09/2017 | 644 |
| Varian John | Director | 12/21/2016 | 77,907 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 12/21/2016 | 18,573 |
| Neal James R | VP Business Development | 11/01/2016 | 788 |
| Neal James R | VP Business Development | 10/07/2016 | 1,120 |
| BURNS THOMAS M. | VP, Finance & Chief Financial | 03/22/2016 | 15,105 |
| Neal James R | VP Business Development | 03/22/2016 | 15,547 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 03/22/2016 | 18,985 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 03/22/2016 | 11,602 |
| Varian John | CEO | 03/22/2016 | 63,578 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 02/01/2016 | 8,080 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 12/28/2015 | 10,937 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 11/23/2015 | 10,800 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 10/26/2015 | 8,358 |
| Varian John | CEO | 08/14/2015 | 29,838 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 08/14/2015 | 5,132 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 08/14/2015 | 9,003 |
| Neal James R | VP Business Development | 08/14/2015 | 7,557 |
| BAKER BROS. ADVISORS LP | Former 10% owner | 07/22/2015 | 12,017,500 |
| Varian John | CEO | 07/15/2015 | 12,400 |
| Varian John | CEO | 07/15/2015 | 44,869 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 07/15/2015 | 15,200 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 07/15/2015 | 22,992 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 07/10/2015 | 88,160 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 07/09/2015 | 13,376 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 07/10/2015 | 131,985 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 07/09/2015 | 20,020 |
| Varian John | CEO | 06/15/2015 | 12,400 |
| Varian John | CEO | 06/15/2015 | 36,362 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 05/28/2015 | 6,437 |
| Varian John | CEO | 05/15/2015 | 12,400 |
| Varian John | CEO | 05/15/2015 | 33,400 |
| Varian John | CEO | 04/15/2015 | 12,400 |
| Varian John | CEO | 04/15/2015 | 38,606 |
| KURLAND FRED | CFO & VP Finance | 04/06/2015 | 127,251 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 03/23/2015 | 128,879 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 03/18/2015 | 34,755 |
| Klein Thomas | Chief Commercial Officer | 03/18/2015 | 212,705 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 03/18/2015 | 82,356 |
| Neal James R | 03/18/2015 | 36,171 | |
| KURLAND FRED | CFO & VP Finance | 03/18/2015 | 36,748 |
| Varian John | CEO | 03/18/2015 | 179,979 |
| Varian John | CEO | 03/16/2015 | 12,400 |
| Varian John | CEO | 03/16/2015 | 37,223 |
| Varian John | CEO | 02/17/2015 | 12,400 |
| Varian John | CEO | 02/17/2015 | 35,192 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 02/02/2015 | 17,622 |
| Varian John | CEO | 01/15/2015 | 12,400 |
| Varian John | CEO | 01/15/2015 | 34,582 |
| BAKER BROS. ADVISORS LP | Director | 01/06/2015 | 3,860,000 |
| BAKER BROS. ADVISORS LP | Director | 01/05/2015 | 3,824,078 |
| BAKER BROS. ADVISORS LP | Director | 01/02/2015 | 753,740 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 01/02/2015 | 17,756 |
| BAKER BROS. ADVISORS LP | Director | 12/29/2014 | 812,440 |
| BAKER BROS. ADVISORS LP | Director | 12/26/2014 | 486,460 |
| BAKER BROS. ADVISORS LP | Director | 12/30/2014 | 1,430,239 |
| BAKER BROS. ADVISORS LP | Director | 12/19/2014 | 3,168,580 |
| BAKER BROS. ADVISORS LP | Director | 12/18/2014 | 710,687 |
| BAKER BROS. ADVISORS LP | Director | 12/17/2014 | 2,958,129 |
| BAKER BROS. ADVISORS LP | Director | 12/12/2014 | 1,196,413 |
| BAKER BROS. ADVISORS LP | Director | 12/16/2014 | 1,363,271 |
| BAKER BROS. ADVISORS LP | Director | 12/15/2014 | 2,050,652 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 12/15/2014 | 4,864 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 12/15/2014 | 7,401 |
| Varian John | CEO | 12/15/2014 | 12,400 |
| Varian John | CEO | 12/15/2014 | 44,929 |
| BAKER BROS. ADVISORS LP | Director | 12/09/2014 | 1,811,062 |
| BAKER BROS. ADVISORS LP | Director | 12/04/2014 | 5,928,902 |
| BAKER BROS. ADVISORS LP | Director | 12/03/2014 | 2,748,837 |
| BAKER BROS. ADVISORS LP | Director | 12/02/2014 | 2,679,550 |
| Neal James R | VP Business Development | 11/26/2014 | 9,514 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 12/01/2014 | 27,569 |
| Neal James R | VP Business Development | 11/24/2014 | 5,193 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 11/20/2014 | 15,200 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 11/20/2014 | 22,750 |
| KURLAND FRED | CFO & VP Finance | 11/13/2014 | 34,148 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 11/13/2014 | 32,093 |
| Varian John | CEO | 11/13/2014 | 10,237 |
| Varian John | CEO | 11/13/2013 | 218,807 |
| Neal James R | VP Business Development | 11/13/2014 | 17,076 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 11/03/2014 | 21,660 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 10/28/2014 | 15,200 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 10/28/2014 | 22,829 |
| Varian John | CEO | 10/15/2014 | 12,400 |
| Varian John | CEO | 10/15/2014 | 38,690 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 10/01/2014 | 20,447 |
| Varian John | CEO | 09/15/2014 | 12,400 |
| Varian John | CEO | 09/15/2014 | 45,577 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 09/15/2014 | 15,200 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 09/15/2014 | 22,938 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 09/04/2014 | 30,400 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 09/04/2014 | 45,640 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 09/02/2014 | 21,553 |
| KURLAND FRED | CFO & VP Finance | 08/15/2014 | 44,780 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 08/18/2014 | 71,752 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 08/15/2014 | 44,341 |
| Neal James R | VP Business Development | 08/15/2014 | 30,322 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 08/15/2014 | 25,277 |
| Varian John | CEO | 08/15/2014 | 12,400 |
| Varian John | CEO | 08/15/2014 | 279,035 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 08/01/2014 | 19,161 |
| Varian John | CEO | 07/15/2014 | 12,400 |
| Varian John | CEO | 07/15/2014 | 40,285 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 07/01/2014 | 23,411 |
| Varian John | CEO | 06/16/2014 | 12,400 |
| Varian John | CEO | 06/16/2014 | 45,410 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 06/16/2014 | 52,595 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 05/28/2014 | 7,533 |
| Varian John | CEO | 05/15/2014 | 12,400 |
| Varian John | CEO | 05/15/2014 | 35,515 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 05/13/2014 | 38,404 |
| Varian John | CEO | 04/15/2014 | 12,400 |
| Varian John | CEO | 04/15/2014 | 40,645 |
| KURLAND FRED | CFO & VP Finance | 03/18/2014 | 37,359 |
| Varian John | CEO | 03/18/2014 | 134,714 |
| Neal James R | VP Business Development | 03/18/2014 | 16,870 |
| Klein Thomas | Chief Commercial Officer | 03/18/2014 | 195,575 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 03/18/2014 | 21,594 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 03/18/2014 | 18,240 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 03/18/2014 | 111,423 |
| Varian John | CEO | 03/17/2014 | 12,400 |
| Varian John | CEO | 03/17/2014 | 60,292 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 02/18/2014 | 18,240 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 02/18/2014 | 45,272 |
| Varian John | CEO | 02/18/2014 | 12,400 |
| Varian John | CEO | 02/18/2014 | 75,478 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 01/21/2014 | 17,310 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 01/21/2014 | 49,608 |
| Varian John | CEO | 01/15/2014 | 12,400 |
| Varian John | CEO | 01/15/2014 | 82,791 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 01/09/2014 | 33,800 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 01/09/2014 | 160,042 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 12/18/2013 | 18,240 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 12/18/2013 | 33,992 |
| Varian John | CEO | 12/16/2013 | 24,800 |
| Varian John | CEO | 12/16/2013 | 108,744 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 12/02/2013 | 33,800 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 12/02/2013 | 120,002 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 11/27/2013 | 14,276 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 11/27/2013 | 21,320 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 11/18/2013 | 3,077 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 11/18/2013 | 5,317 |
| Varian John | CEO | 11/15/2013 | 12,400 |
| Varian John | CEO | 11/15/2013 | 41,329 |
| Varian John | CEO | 11/13/2013 | 214,938 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 11/13/2013 | 32,660 |
| KURLAND FRED | CFO & VP Finance | 11/13/2013 | 48,244 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 10/18/2013 | 24,725 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 10/18/2013 | 1,761 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 10/18/2013 | 3,511 |
| Varian John | Director and CEO | 10/15/2013 | 12,400 |
| Varian John | Director and CEO | 10/15/2013 | 45,950 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 09/30/2013 | 1,958 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 09/18/2013 | 27,187 |
| Varian John | Director and CEO | 09/16/2013 | 12,400 |
| Varian John | Director and CEO | 09/16/2013 | 45,862 |
| BAKER BROS. ADVISORS LP | Director | 08/19/2013 | 9,983,203 |
| BAKER BROS. ADVISORS LP | Director | 08/19/2013 | 9,983,203 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 08/19/2013 | 22,419 |
| Varian John | Director and CEO | 08/15/2013 | 12,400 |
| Varian John | Director and CEO | 08/14/2013 | 199,419 |
| Varian John | Director and CEO | 08/15/2013 | 39,212 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 08/14/2013 | 40,621 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 08/14/2013 | 23,175 |
| KURLAND FRED | CFO & VP Finance | 08/14/2013 | 28,951 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 07/18/2013 | 16,371 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 07/18/2013 | 28,233 |
| Varian John | Director and CEO | 07/15/2013 | 12,400 |
| Varian John | Director and CEO | 07/15/2013 | 48,066 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 06/28/2013 | 1,955 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 06/18/2013 | 7,387 |
| Varian John | Director and CEO | 06/17/2013 | 12,400 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 06/11/2013 | 16,900 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 05/29/2013 | 7,476 |
| WYSZOMIERSKI JACK L | Director | 05/28/2013 | 7,532 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 05/20/2013 | 1,853 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 05/20/2013 | 3,266 |
| SCANNON PATRICK J MD PHD | Exec. VP & CSO | 05/14/2013 | 16,900 |
| Varian John | Director and CEO | 05/15/2013 | 12,400 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 03/28/2013 | 4,967 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 03/19/2013 | 22,997 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 12/31/2012 | 1,899 |
| Varian John | Director and CEO | 11/14/2012 | 103,807 |
| SCANNON PATRICK J MD PHD | Executive Vice President | 11/14/2012 | 22,445 |
| KURLAND FRED | CFO & VP Finance | 11/14/2012 | 23,310 |
| BAKER JULIAN | Director | 10/29/2012 | 14,167,998 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 09/28/2012 | 1,900 |
| RUBIN PAUL D | Sr. VP Clinical Dev. & CMO | 06/29/2012 | 1,871 |
| RUBIN PAUL D | VP Clinical Dev. & CMO | 03/30/2012 | 3,234 |
| VAN NESS W DENMAN | Director | 11/11/2011 | 1,117 |
| RUBIN PAUL D | VP Clinical Dev. & CMO | 09/30/2011 | 1,699 |
| KURLAND FRED | CFO & VP Finance | 03/25/2011 | 16,320 |
Load More Insider Transactions
FUNDS WITH A POSITION IN XOMA CORP
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 457,487 | 0.00019% | 6.71% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 156,731 | 0.00026% | 1.84% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 18,205 | 0.00044% | -61.35% | Other |
CHANGE IN SHARES OUTSTANDING FOR XOMA CORP
STOCK BUYBACKS FOR XOMA CORP
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 09/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
06/30/2023
0.06%
1Q
03/31/2023
0.11%
2Q
12/31/2022
0.18%
3Q
09/30/2022
0.23%
4Q
06/30/2022
0.46%
5Q
03/31/2022
1.26%
6Q
12/31/2021
-5.90%
7Q
09/30/2021
1.43%
8Q
06/30/2021
1.67%
9Q
03/31/2021
2.07%
10Q
12/31/2020
-0.26%
11Q
09/30/2020
4.12%
12Q
06/30/2020
6.00%
13Q
03/31/2020
17.54%
14Q
12/31/2019
30.93%
15Q
09/30/2019
21.52%
16Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR XOMA CORP
LOADING...